135 related articles for article (PubMed ID: 20166899)
1. Nerve growth factor signaling in prostate health and disease.
Arrighi N; Bodei S; Zani D; Simeone C; Cunico SC; Missale C; Spano P; Sigala S
Growth Factors; 2010 Jun; 28(3):191-201. PubMed ID: 20166899
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.
Sigala S; Bodei S; Missale C; Zani D; Simeone C; Cunico SC; Spano PF
Mol Cell Endocrinol; 2008 Mar; 284(1-2):11-20. PubMed ID: 18280641
[TBL] [Abstract][Full Text] [Related]
4. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
[TBL] [Abstract][Full Text] [Related]
5. Nerve growth factor and tissue repair remodeling: trkA(NGFR) and p75(NTR), two receptors one fate.
Micera A; Lambiase A; Stampachiacchiere B; Bonini S; Bonini S; Levi-Schaffer F
Cytokine Growth Factor Rev; 2007; 18(3-4):245-56. PubMed ID: 17531524
[TBL] [Abstract][Full Text] [Related]
6. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of the nerve growth factor network in prostate cancer.
Papatsoris AG; Liolitsa D; Deliveliotis C
Expert Opin Investig Drugs; 2007 Mar; 16(3):303-9. PubMed ID: 17302525
[TBL] [Abstract][Full Text] [Related]
8. Cotransfection of TrkA and p75(NTR) in neuroblastoma cell line (IMR-32) promotes differentiation and apoptosis of tumor cells.
Chen J; Zhe X
Chin Med J (Engl); 2003 Jun; 116(6):906-12. PubMed ID: 12877805
[TBL] [Abstract][Full Text] [Related]
9. Increased nerve growth factor and its receptors in atopic dermatitis: an immunohistochemical study.
Dou YC; Hagströmer L; Emtestam L; Johansson O
Arch Dermatol Res; 2006 Jun; 298(1):31-7. PubMed ID: 16586073
[TBL] [Abstract][Full Text] [Related]
10. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
[TBL] [Abstract][Full Text] [Related]
11. Expression levels of the nerve growth factor receptors TrkA and p75 in effusions and solid tumors of serous ovarian carcinoma patients.
Davidson B; Lazarovici P; Ezersky A; Nesland JM; Berner A; Risberg B; Tropé CG; Kristensen GB; Goscinski M; van de Putte G; Reich R
Clin Cancer Res; 2001 Nov; 7(11):3457-64. PubMed ID: 11705863
[TBL] [Abstract][Full Text] [Related]
12. [Changes of nerve growth factor and its receptors in the lung tissues in asthmatic rats and their effects on the airway inflammation].
Ouyang RY; Hu CP; Zhu JQ; Huang XG
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):660-5. PubMed ID: 16708804
[TBL] [Abstract][Full Text] [Related]
13. Overexpressions of nerve growth factor and its tropomyosin-related kinase A receptor on chordoma cells.
Park JB; Lee CK; Koh JS; Lee JK; Park EY; Riew KD
Spine (Phila Pa 1976); 2007 Aug; 32(18):1969-73. PubMed ID: 17700442
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines.
Pflug BR; Onoda M; Lynch JH; Djakiew D
Cancer Res; 1992 Oct; 52(19):5403-6. PubMed ID: 1382843
[TBL] [Abstract][Full Text] [Related]
15. Effect of p75NTR on the regulation of naturally occurring cell death and retinal ganglion cell number in the mouse eye.
Harada C; Harada T; Nakamura K; Sakai Y; Tanaka K; Parada LF
Dev Biol; 2006 Feb; 290(1):57-65. PubMed ID: 16343477
[TBL] [Abstract][Full Text] [Related]
16. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
[TBL] [Abstract][Full Text] [Related]
17. Chronic nerve growth factor exposure increases apoptosis in a model of in vitro induced conjunctival myofibroblasts.
Micera A; Puxeddu I; Balzamino BO; Bonini S; Levi-Schaffer F
PLoS One; 2012; 7(10):e47316. PubMed ID: 23071784
[TBL] [Abstract][Full Text] [Related]
18. Presence of NGF and its receptors in ovaries from human fetuses and adults.
Abir R; Fisch B; Jin S; Barnnet M; Ben-Haroush A; Felz C; Kessler-Icekson G; Feldberg D; Nitke S; Ao A
Mol Hum Reprod; 2005 Apr; 11(4):229-36. PubMed ID: 15829579
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors.
Anagnostopoulou V; Pediaditakis I; Alkahtani S; Alarifi SA; Schmidt EM; Lang F; Gravanis A; Charalampopoulos I; Stournaras C
Endocrinology; 2013 Jul; 154(7):2446-56. PubMed ID: 23696568
[TBL] [Abstract][Full Text] [Related]
20. TrkA as a life and death receptor: receptor dose as a mediator of function.
Yan C; Liang Y; Nylander KD; Schor NF
Cancer Res; 2002 Sep; 62(17):4867-75. PubMed ID: 12208732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
